非肥胖妊娠糖尿病:对母亲和胎儿的结果具有独特的风险概况
1Department of Obstetrics and Gynecology, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Medicine
|November 15, 2025
概括
患有妊娠糖尿病 (GDM) 的肥胖女性面临更高的并发症风险,如子宫前和剖腹产. 然而,对于所有GDM患者来说,无论身体质量指数 (BMI) 是什么,保持警监测至关重要,以确保母亲和新生儿的健康.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 围产儿医学 围产儿医学
背景情况:
- 孕期糖尿病 (GDM) 是一种常见的妊娠并发症.
- 身体质量指数 (BMI) 对GDM结果的影响需要进一步澄清.
- 了解BMI的独立影响对于有针对性的干预至关重要.
研究的目的:
- 为了比较非肥胖和肥胖的GDM患者之间的孕产妇和新生儿结局.
- 为了确定BMI是否独立地影响GDM的不良怀孕事件.
- 为了确定GDM怀孕中并发症的危险因素.
主要方法:
- 400名GDM患者 (200名非肥胖者,200名肥胖者) 的回顾性研究.
- 数据提取包括人口统计,临床参数和孕产妇/新生儿结局.
- 统计分析包括标准测试和多变量后勤回归.
主要成果:
- 肥胖的GDM患者患有妊娠前,剖腹产,巨和NICU入院的风险明显更高.
- 体重指数升高和高糖血红蛋白是不良结果的独立风险因素.
- 非肥胖的GDM患者经历的并发症较少,但仍然面临重大风险.
结论:
- 体重指数 (BMI) 是GDM不良结果的独立风险因素.
- 综合管理,包括血糖控制和围产期随访,对于所有GDM患者至关重要.
- 早期检测和监测可以减轻并发症,并改善整个BMI类别的母胎健康.
相关概念视频
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Drug Dosing: Obese Patients
208
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
208


